Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes ...

One of the most difficult issues to deal with as a cancer survivor is the positivity trap. Four and a half years ago, I was diagnosed with follicular lymphoma, a form of blood cancer that is ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

A 66-year-old man was referred to our dermatology clinic for a 6-year history of a progressive pruritic rash, refractory to ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

FDA Approves New Drug Combination for Mantle Cell LymphomaThe FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). If you have follicular ...